Search clinical trials for: metronomic cyclophosphamide

Total 3687 results

European Institute of Oncology

Recruiting

Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients (VEX)

Advanced Breast Cancer

Italy
Immune Design

Terminated

Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1

Melanoma | Sarcoma | Ovarian Cancer | Non-small Cell Lung Cancer

United States
Nicklaus Children's Hospital f/k/a Miami Children...
Florida International University

Completed

Use of a Metronome in Cardiopulmonary Resuscitation: A Simulation Study

Cardiac Arrest
Ruijin Hospital

Unknown

Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
Centre Jean Perrin

Terminated

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes

Metastatic Breast Cancer

France
Sun Yat-sen University

Recruiting

Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer (Increase)

Breast Cancer

China
Huashan Hospital

Recruiting

Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer

Gastric Cancer

China
Cliniques universitaires Saint-Luc- Université...

Completed

Autocorrelated Rhythmic Auditory Stimulations for Parkinson's Disease Patients

Parkinson Disease
The Defense and Veterans Brain Injury Center

Completed

"Interactive Metronome Technology for Blast-Related Traumatic Brain Injury"

Traumatic Brain Injury | Post-Concussion Syndrome

United States
University of North Carolina, Chapel Hill

Completed

The Effects of Auditory Cues on Gait Mechanics in Parkinson's Disease

Parkinson Disease

United States
University Hospital of Cologne

Unknown

Comparison of the Quality of CPR by Lay Rescuers With and Without Feedback Devices (frequenz)

Cardiac Arrest

Germany
Sun Yat-sen University
Chengdu Biostar Pharmaceuticals

Not yet recruiting

Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms | Locally Advanced or Metastatic Breast Cancer

China
Hospices Civils de Lyon

Completed

Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients (ENDOLA)

Recurrent Endometrial Cancer

France
Institut Bergonié
Merck Sharp & Dohme LLC; Ministry of Health, France; Immune Design

Active, not recruiting

Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial (PEMBROSARC)

Sarcoma

France
Massachusetts General Hospital
Agency for Healthcare Research and Quality (AHRQ)

Completed

The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care

Hypertension | Diabetes Mellitus, Type 2 | Hyperlipidemia

United States
Centre Hospitalier Universitaire de Besancon

Completed

Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors (EPICentro)

Neuroendocrine Tumors

France
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Metronom Health
Medical University of Graz

Unknown

Metronom Continuous Glucose Monitoring System

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabete Mellitus

Austria, Denmark
Ospedale Generale Di Zona Moriggia-Pelascini

Unknown

Effects of Auditory Stimulation During Verticalization With Erigo in Patients With Disorder of Consciousness

Consciousness Disorders

Italy
University of Oxford

Completed

Investigating Non-invasive Brain Stimulation to Enhance Fluency in People Who Stutter (INSTEP)

Stuttering, Developmental

United Kingdom
Instituto do Cancer do Estado de São Paulo
Fundação Faculdade de Medicina

Terminated

Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01)

Locally Advanced HER2-positive Breast Cancer

Brazil
Washington University School of Medicine

Completed

Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors (ASCR)

Glioma | Neuroectodermal Tumors, Primitive | Osteosarcoma | Sarcoma, Ewing | Retinoblastoma | Rhabdomyosarcoma | Wilms Tumor

United States
Fudan University

Recruiting

Metronomic Capecitabine in Stage III Gastric Cancer

Gastric Cancer

China
Otto Wagner Hospital

Completed

Effects of Dynamic Hyperinflation on the Left-ventricular Diastolic Function in Healthy Male Subjects

Pulmonary Disease, Chronic Obstructive

Austria
European Organisation for Research and Treatment...
Hoffmann-La Roche

Completed

Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1

Elderly Metastatic Breast Cancer Population

Belgium, Italy, Netherlands, France, Poland, United Kingdom, Portugal, Sweden
Instituto do Cancer do Estado de São Paulo
Fundação Faculdade de Medicina

Terminated

Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast Cancer (TAME-01)

Locally Advanced HER2-negative Breast Cancer

Brazil
Leo W. Jenkins Cancer Center

Terminated

Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer

Breast Cancer

United States
Swami Rama Cancer Hospital and Research Institute

Unknown

Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma

Lung Cancer | Squamous Cell Carcinoma of the Lung | Locally Advanced and Metastatic Squamous Cell Carcinoma of the Lung

India
Aultman Health Foundation

Completed

Effects of a Metronome on Functional Outcomes in Aquatic Therapy

Exercise Therapy

United States
Veterans Health Service Medical Center, Seoul,...

Completed

Comparison of Sensory Cuing Modalities for Freezing of Gait

Parkinson Disease

Korea, Republic of
Yan Xue

Recruiting

Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients

Breast Cancer

China
Fujian Cancer Hospital

Not yet recruiting

Almonertinib Plus Metronomic Oral Vinorelbine

NSCLC | EGFR | Third-generation TKI
National Cancer Centre, Singapore
Tan Tock Seng Hospital; BeiGene

Not yet recruiting

Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Singapore
The Netherlands Cancer Institute

Terminated

Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

Breast Cancer

Netherlands
Mayo Clinic

Recruiting

Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
National Cancer Institute, Egypt

Completed

Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients

Toxicity | Survival | Clinical Response
Beijing Tiantan Hospital

Recruiting

Association Between Dietary Factors and Chronic Subdural Hematoma (DISH) (DISH)

Chronic Subdural Hematoma

China
Fujian Cancer Hospital

Enrolling by invitation

Metronomic Oral Vinorelbine Combination With Tislelizumab in EGFR/ALK-negative Advanced NSCLC

EGFR/ ALK-negative Advanced NSCLC

China
Binghe Xu
Hoffmann-La Roche

Unknown

Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC (CAMELLIA)

Skin Diseases | Neoplasms by Site | Breast Neoplasms | Breast Diseases | Neoplasm Metastasis

China
AIDS Malignancy Consortium
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center

Not yet recruiting

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

HIV Infection | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent... and other conditions
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer

Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant... and other conditions

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma

United States
UNICANCER
AstraZeneca; National Cancer Institute, France; Pierre Fabre Laboratories

Active, not recruiting

Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours (MOVIE)

Breast Cancer | Head and Neck Cancer | Prostate Cancer | Cervix Cancer | Advanced Solid Tumours

France
Peking University People's Hospital

Recruiting

ATG Plus Low-dose PT-Cy for GVHD Prevention

Hematologic Malignancy

China
Priv.-Doz. Dr. med. Joachim Rom

Completed

Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer

Epithelial Ovarian Cancer

Germany
Hvidovre University Hospital
Novo Nordisk A/S; Technical University of Denmark

Completed

DiaCon Overnight Closed-Loop Glucose Control Study (DiaCon2)

Type 1 Diabetes

Denmark
Heat Biologics

Terminated

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma

Hematopoietic and Lymphoid Cell Neoplasm | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent... and other conditions

United States
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer

Breast Cancer

China

Search clinical trials for: metronomic cyclophosphamide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations